Cargando…

Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma

Detalles Bibliográficos
Autores principales:	Bawany, Fatima, Ramachandran, Vignesh, Rodriguez, Eduardo, Kim, Randie H., Weber, Jeffrey S., Tattersall, Ian W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568223/ https://www.ncbi.nlm.nih.gov/pubmed/37842150 http://dx.doi.org/10.1016/j.jdcr.2023.08.040

Ejemplares similares

Linear IgA Bullous Dermatosis
por: Chen, Sean, et al.
Publicado: (2013)

Linear IgA and IgG bullous dermatosis
por: Fernandes, Karina de Almeida Pinto, et al.
Publicado: (2016)

Linear IgA bullous dermatosis treated with rituximab
por: Pinard, Camille, et al.
Publicado: (2019)

Linear IgA bullous dermatosis: report of an exuberant case
por: de Souza, Beatriz Cavalcanti, et al.
Publicado: (2013)

Adult linear IgA bullous dermatosis: report of three cases
por: Machado, Taila Yuri Siqueira, et al.
Publicado: (2018)

A Case of Drug-induced Linear IgA Bullous Dermatosis
por: Dessie, Sofanit A, et al.
Publicado: (2020)

Azithromycin as a Possible Cause of Linear IgA Bullous Dermatosis
por: O’Connell, Cailin, et al.
Publicado: (2023)

Linear IgA bullous dermatosis associated with metastatic renal cell carcinoma
por: Yang, Catherine S., et al.
Publicado: (2015)

Linear IgA bullous dermatosis: a rare side effect of vancomycin
por: Selvaraj, Pradeep K., et al.
Publicado: (2013)

Linear IgA bullous dermatosis protracted by vancomycin-loaded bone cement
por: Nartker, Nathan, et al.
Publicado: (2019)

Vancomycin‐induced linear IgA bullous dermatosis (LABD)—an atypical presentation
por: Visentainer, Lorena, et al.
Publicado: (2019)

A Case of Linear IgA Bullous Dermatosis Successfully Treated with Omalizumab
por: Patel, Nayankumar H, et al.
Publicado: (2020)

Diffuse cutaneous mastocytosis masquerading as linear IgA bullous dermatosis of childhood
por: Rayinda, Tuntas, et al.
Publicado: (2021)

Vancomycin-induced linear IgA bullous dermatosis in a patient with cancer
por: Itoh, Naoya, et al.
Publicado: (2022)

Linear IgA bullous dermatosis preceding a diagnosis of Crohn’s disease
por: Sadeghi, Nakisa B., et al.
Publicado: (2023)

Linear IgA bullous dermatosis and elevated bullous interleukin‐6 levels: Responsive to treatment with Anti‐IL‐6 receptor monoclonals
por: Jordan, Stanley C., et al.
Publicado: (2023)

Linear IGA bullous dermatosis potentially triggered by vaccination
por: Corrà, Alberto, et al.
Publicado: (2022)

A Case of Linear IgA Bullous Dermatosis Associated with Systemic Lupus Erythematosus
por: Lee, Ho-June, et al.
Publicado: (2016)

Response to “Linear IgA bullous dermatosis protracted by vancomycin-loaded bone cement”
por: Gurung, Puran, et al.
Publicado: (2019)

Linear IgA bullous dermatosis successfully treated with omalizumab: A case report
por: Maalouf, Nadine S., et al.
Publicado: (2019)

Linear IgA bullous dermatosis with Koebner phenomenon in a liver transplant patient
por: Ptak, Bartosz, et al.
Publicado: (2022)

Linear Immunoglobulin A (IgA) Bullous Dermatosis Mimicking Stevens-Johnson Syndrome
por: Park, Jason S, et al.
Publicado: (2022)

Linear IgA Bullous Dermatosis Attributable to the Use of Spironolactone: A Case Report
por: Philip, Vineetha, et al.
Publicado: (2023)

Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab
por: Nedosekin, Dmitry, et al.
Publicado: (2021)

Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A case report
por: Haulrig, Morten Bahrt, et al.
Publicado: (2022)

UNUSUAL CLINICOPATHOLOGICAL AND IMMUNOLOGICAL PRESENTATION OF CHRONIC BULLOUS DERMATOSIS OF CHILDHOOD (LINEAR IGA DERMATOSIS)
por: Fahad, Al-Saif, et al.
Publicado: (2011)

LINEAR IGA BULLOUS DERMATOSIS IN TUNISIAN CHILDREN: 31 CASES
por: Monia, Kharfi, et al.
Publicado: (2011)

Management Options for Linear Immunoglobulin A (IgA) Bullous Dermatosis: A Literature Review
por: Khan, Madiha, et al.
Publicado: (2023)

Development of cyclosporine-induced linear IgA bullous dermatosis despite concurrent use of dapsone
por: Libson, Karissa, et al.
Publicado: (2023)

Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology
por: do Vale, Everton Carlos Siviero, et al.
Publicado: (2019)

Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis
por: Akasaka, Eijiro, et al.
Publicado: (2015)

Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients
por: Genovese, Giovanni, et al.
Publicado: (2019)

Piperacillin-Tazobactam-Induced Linear IgA Bullous Dermatosis Supported by a T-Cell Activation Assay
por: Ho, Yi-Hsin, et al.
Publicado: (2018)

Elasomeran/terbinafine: Toxic epidermal necrolysis-like linear IgA bullous dermatosis: case report
Publicado: (2022)

Urticarial linear IgA bullous dermatosis (LABD) as a presenting sign of chronic lymphocytic leukemia (CLL)
por: Tiger, Jeffrey B., et al.
Publicado: (2015)

Systemic Lupus Erythematosus with Linear IgA Bullous Dermatosis and Renal Vascular Lesions: An Extremely Rare Association
por: Malipatel, R., et al.
Publicado: (2018)

Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports
por: Herlin, Laura Krogh, et al.
Publicado: (2022)

Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review
por: Zhou, Yuxi, et al.
Publicado: (2023)

Ocular Involvement and Blindness Secondary to Linear IgA Dermatosis
por: Ramos-Castellón, Cinthya, et al.
Publicado: (2010)

Revisiting the “jelly-roll” technique: New utility in diagnosing linear IgA bullous dermatosis mimicking toxic epidermal necrolysis
por: Khan, Samavia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rq72sn2htr4176v5ti7hgsd6mt